Ever Supreme Bio Technology Co., Ltd (TPEX:6712)
154.00
+2.00 (1.32%)
Feb 11, 2026, 1:30 PM CST
TPEX:6712 Market Cap
TPEX:6712 has a market cap or net worth of 13.31 billion as of February 11, 2026. Its market cap has decreased by -6.75% in one year.
Market Cap
13.31B
Enterprise Value
13.00B
Revenue
1.01B
Ranking
n/a
PE Ratio
25.79
Stock Price
154.00
Market Cap Chart
Since October 26, 2018, TPEX:6712's market cap has increased from 5.10B to 13.31B, an increase of 161.28%. That is a compound annual growth rate of 14.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 9, 2026 | 13.31B | -7.32% |
| Dec 31, 2025 | 14.37B | 1.47% |
| Dec 31, 2024 | 14.16B | -1.25% |
| Dec 29, 2023 | 14.34B | -4.57% |
| Dec 30, 2022 | 15.02B | 15.46% |
| Dec 30, 2021 | 13.01B | 32.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sunmax Biotechnology | 21.35B |
| EirGenix | 18.28B |
| TaiMed Biologics | 14.89B |
| AP Biosciences | 14.72B |
| Tanvex BioPharma | 13.07B |
| Medigen Vaccine Biologics | 11.98B |
| TCM Biotech International | 10.81B |
| Gongwin Biopharm Holdings | 9.00B |